Anthropic's $64 Billion IPO Prices Wednesday: What Retail Investors Should Know
Nov 17, 2026 · Trading Tips
The biggest AI listing yet is days away. Anthropic, the company behind the Claude chatbot, is expected to price its IPO Wednesday evening and begin trading on the Nasdaq under the ticker ANT on Thursday.
The stakes go well beyond one company. A strong debut could re-energize an AI trade that has been shaky for weeks. A stumble could do the opposite.
Here's the setup. Anthropic plans to sell 825 million Class A shares at $70 to $78 each. As The New York Times reported, that range values the company at roughly $1.26 trillion to $1.41 trillion once every share is counted.
That's below the $2 trillion figure bankers floated this summer. It's still well above the $900 billion private valuation Anthropic held before filing.
Demand looks heavy. Bloomberg reported Thursday that the order book was about six times the shares available, and later reports put it closer to seven times. Seven big tech names, including Google, Nvidia and Microsoft, have signed up to buy a combined $26 billion of stock in the offering.
At the top of the range, Kiplinger's IPO explainer puts the deal at more than $64 billion at a $1.405 trillion valuation. That would rank among the largest IPOs ever, though still behind SpaceX's offering in June.
The financials are a study in contrasts. Anthropic's annualized revenue reportedly hit $65 billion by the end of July, and the company has signed agreements for at least $518 billion of AI infrastructure spending over the next decade. About 80% of those commitments can't be canceled.
That's a giant bet that AI demand keeps compounding. A Boston Consulting Group survey cited by Kiplinger found fewer than half of companies are getting meaningful value from AI, even as spending has nearly doubled in a year.
"I do think there will be a bit of hype and frenzy around the name, given that it will be the first major generative AI pure play to come to market." — Avery Marquez, Director of Investment Strategies, Renaissance Capital
That frenzy is the first thing to plan around. A six-times-covered book gives underwriters room to price at the top of the range or above it, and the first-day pop, if there is one, will be set by institutions before most retail accounts see a share.
Here's the catch for everyday investors. Reports say underwriters told prospective buyers that allocations would favor existing shareholders, leaving some buyers with less than they expected. Plenty of brokerage customers won't get shares at the offer price at all.
If you don't get an allocation, you'll be buying in the open market on Thursday, at whatever price the crowd sets. That's a very different trade from buying at $70 to $78.
Heavy oversubscription also isn't a value judgment. Plenty of deals in the 2020-2021 IPO boom drew huge order books and traded below their offer price within a year. Demand tells you the story is hot, not that the price is right.
The risks are real. Competition from Google and other rivals could pressure Claude's premium pricing. Reuters-sourced reports noted some investors left roadshow meetings wanting more detailed answers, and the valuation leans on projected 2028 revenue of roughly $270 billion to $280 billion.
The same day-one volatility applies to the wider market. A weak debut would be a bad signal for the AI names that have already been sold off, including the chip and cloud stocks tied to Anthropic's spending plans.
So what should you do? If you hold AI-heavy funds or megacap tech, you already own a slice of this story through Nvidia, Alphabet, Amazon and Microsoft. Check how concentrated you are before you add a new position.
If you do want ANT itself, decide your size in advance and treat the first-day price as noise. A limit order beats a market order in a name that could swing double digits in the opening minutes. Staging purchases over several weeks, once the first trading days settle, is a calmer way in.
Watch Wednesday's final price versus the $70-$78 range, Thursday's opening trade, and how Nvidia and the Nasdaq react. Those three data points will tell you a lot about appetite for AI risk.
The bottom line: the demand is real, but the shares you can actually get may not be the shares you want.